Lessons from the Helsinki Heart Study. Fibric acid therapy for dyslipidemia.
Grundy
S M
SM
Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas 75235.
D000328:Adult; D001647:Bile Acids and Salts / Q000378:metabolism; D008076:Cholesterol, HDL / Q000378:metabolism; D008078:Cholesterol, LDL / Q000378:metabolism; D003327:Coronary Disease / Q000517:prevention & control*; D015248:Gemfibrozil; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008074:Lipoproteins / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010421:Pentanoic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D014280:Triglycerides / Q000378:metabolism; D014631:Valerates / Q000627:therapeutic use*
D001647:Bile Acids and Salts; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D010421:Pentanoic Acids; D014280:Triglycerides; D014631:Valerates; D015248:Gemfibrozil